Products
Early start to 8CPA talks under consideration
Next CPA must be about “more than dispensing revenue”, Minister says Negotiations for the Eighth Community Pharmacy Agreement (8CPA) could be brought forward, in response to concerns around 60-day dispensing. …
Over-the-counter options for reflux: Gaviscon & Guardium
Troublesome symptoms of gastro-oesophageal reflux disease (GORD) affect approximately 14% of adults.1 While symptoms may vary from patient to patient, heartburn and acid regurgitation are the most commonly reported symptoms.2 …
Gerald Tracey: Collaborative care and supporting the transition to biosimilars
Rheumatologist, Dr Gerald Tracey explains the opportunities biosimilars present for prescribing physicians, particularly given the government supported streamlined process. Gerald highlights the advantages of collaborative care between the prescriber and …
Trent Twomey: The role of pharmacists and physicians in supporting a patient-centric narrative
Trent Twomey, the National President of the Pharmacy Guild of Australia highlights the shifting power dynamic from physicians to patients in determining what medicines they are prescribed. Collaborative care is …
Andrew Oster: The power of collaborative care in transitioning to biosimilars
Professor Andrew Oster, Consultant Rheumatologist at the Cabrini Medical Centre in Malvern, Victoria, explains the opportunities biosimilars bring, allowing patients to switch medications. Given the interchangeability of biosimilars, he emphasises …
Eric Chan: Cultivating a relationship of trust between pharmacist and physician
Head of Pharmacy at Blooms The Chemist, Eric Chan emphasises the importance of collaborative care in cultivating a relationship of trust and transparency between a pharmacist and physician. He outlines …
George Tambassis: Empowering and educating pharmacists on biosimilars
George Tambassis, Pharmacist, ex-National Guild President, and chair of the Australian Biosimilar Academy Advisory Board outlines the importance of pharmacist involvement in understanding biosimilars. Given the government supported Community Pharmacy …
Professor Andrew McLachlan presents the recent trends and gaps identified in OA pain management
In this video, Professor Andrew McLachlan discusses how a patient’s health literacy can impact their choice of self-management strategies for OA symptoms and how a lack of condition awareness can …
Professor Andrew McLachlan explains how pharmacists play a critical role in identifying and supporting patients with Osteoarthritis
A recent study found only 3.5% of participants with self-reported OA symptoms sought advice from a pharmacist despite the critical role pharmacists play in helping patients on their pain management …